The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

Morabaha Marina Financing Co. (MRNA) said it will not be able to release its preliminary financial results for the ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in April, moving ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

Biotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...

Klothea Bio Inc., a biotechnology company pioneering mRNA-based therapies to upregulate the anti-aging protein Klotho, today announced its ongoing collaboration with Healthy Longevity Clinic (HLC), ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

A study from Karolinska Institutet reveals how cells adapt to nutrient scarcity by altering their genetic instructions. This ...

In late April, Summit Therapeutics revealed interim OS data from HARMONi-2 for its PD-1/VEGF bispecific antibody, ivonescimab ...